Woodline Partners »

Arcellx shares owned by Woodline Partners

Quarter-by-quarter ownership of Arcellx (ACLX) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Arcellx

Tip: Access up to 7 years of quarterly data

All positions including Arcellx held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcellx by Woodline Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $9.3M 111k 83.51
2024-06-30 $5.9M 108k 55.19
2024-03-31 $7.2M 104k 69.55

More positions owned by Woodline Partners

Meta Platforms Cl A (META)
Gilead Sciences (GILD)
Abbvie (ABBV)
Revolution Medicines (RVMD)
Vaxcyte (PCVX)
Asml Holding N V N Y Registry Shs (ASML)
Nuvalent Inc-a (NUVL)
Permian Resources Corp Class A Com (PR)
Encana Corporation (OVV)
Keysight Technologies (KEYS)
Danaher Corporation (DHR)
Aon Shs Cl A (AON)
Stmicroelectronics N V Ny Registry (STM)
Regeneron Pharmaceuticals (REGN)
EQT Corporation (EQT)

View all positions for Woodline Partners

Top funds holding Arcellx

Paradigm Biocapital Advisors
BlackRock
Perceptive Advisors
NEA Management Company
BlackRock
Sr One Capital Management
Vanguard Group
Henderson Group
T. Rowe Price Associates
RA Capital Management
State Street Corporation
Cormorant Asset Management
Suvretta Capital Management
Susquehanna International
Geode Capital Management

View all funds holding Arcellx